Independent pharmacies are facing some of the most challenging financial conditions in decades. Declining reimbursement rates, persistent pressure from pharmacy benefit managers (PBMs), rising labor costs, and inflation have combined to create an environment where even successful pharmacies can struggle financially. As a result, the number of independent community pharmacies continues to decline, with 30.3% of independent pharmacy owners considering closing their business in 2025.¹ Direct and indirect remuneration fees restructured into point-of-sale adjustments have not delivered the relief many hoped for, while PBM reimbursements on generics continue to dip below acquisition cost on a disturbingly regular basis.

Against this backdrop, financial strategy has become central to pharmacy leadership rather than a back-office function. Independent pharmacy owners are increasingly required to think like financial managers, balancing short-term liquidity with long-term viability while making disciplined decisions about expenses, debt, and growth investments. The good news is that independent pharmacies have a long history of adapting. The owners who are surviving, and in some cases thriving, are treating their pharmacy's finances with the same rigor they bring to patient care.

Building a Financial Road Map Through Budgeting

It sounds basic, but it isn't. A surprising number of independent pharmacy owners operate without a formal, updated budget, relying instead on a general sense of what's coming in and what's going out. That approach was somewhat workable when margins were stronger, but today, it’s a liability. A pharmacy owner cannot develop an effective strategy without understanding the pharmacy’s financial performance, including sources of revenue, areas of loss, and points where cash flow is delayed or restricted. Regularly reviewing key performance indicators such as gross margins, inventory turns, payroll, and vendor costs helps give owners a clear picture of the pharmacy’s performance and efficiency.

Developing a functional pharmacy budget needs to go beyond just reviewing the income statement. In looking at the budget, labor is typically the largest controllable expense in a pharmacy, often running 55% to 65% of total operating costs. Owners should regularly evaluate staffing patterns against prescription volume, immunization demand, medication synchronization programs, and clinical service offerings to ensure labor resources are being deployed efficiently. Are your technician hours aligned with your busiest dispensing windows? Are you paying overtime that could be restructured? Small inefficiencies in scheduling can compound quickly. In addition, overhead costs, including rent, utilities, software, and insurance, should be audited annually.

Inventory is the second key driver. With reimbursement often lagging acquisition costs, excess inventory can quickly become a significant drain on working capital. The average independent pharmacy carries far more inventory than it needs. One key measure of inventory efficiency is inventory turns, with a target of approximately 15 turns per year. Pharmacies achieving fewer than 12 turns annually are often carrying excess inventory, which ties up valuable cash and increases holding costs. Improving inventory performance from 10 to 12 turns per year to the 15-turn benchmark can typically reduce on-hand inventory by 10% to 20%. For many pharmacies, this translates into approximately $15,000 to $60,000 in freed-up cash that can be reinvested in operations, growth initiatives, or other strategic priorities.² This can be done by implementing a tighter par-level system, working with a primary wholesaler that offers automated reorder tools, and simply reviewing slow-moving products routinely.

Although budgeting helps identify inefficiencies and opportunities to free up capital, maintaining adequate cash flow remains an ongoing challenge even for well-managed pharmacies.

Managing the Reimbursement Gap for Cash Flow

Profitability and cash flow are not the same thing, and confusing them is one of the most dangerous mistakes an independent pharmacy owner can make. A pharmacy can show a profit on paper and still be unable to make payroll if receivables are slow or inventory costs spike. The core of cash flow management is timing. Independent pharmacies typically pay their wholesaler weekly, often within 7 to 14 days of receiving product. Reimbursement from PBMs, on the other hand, can take anywhere from 2 to 6 weeks, depending on the payer. That gap is where cash flow crises are born. According to a survey of more than 500 independent pharmacy owners conducted by the NCPA, 67% reported waiting more than 22 days for manufacturer refunds, well beyond the standard 14-day prompt-pay timeframe for Medicare Part D electronic claims. In addition, 22% reported waiting longer than 28 days.³

Prior NCPA findings estimated that these delays create an average cash flow burden of approximately $11,000 per pharmacy. The latest survey results further highlight the operational impact of these delays, with 70% of respondents reporting that they are limiting the inventory of high-cost medications and 60% indicating that they have had to rely on personal or business savings to support ongoing operations.

Given these reimbursement delays, weekly or biweekly cash flow forecasting has become increasingly important. Regular forecasting allows owners to anticipate shortfalls, adjust purchasing decisions, and avoid unnecessary borrowing. Owners should map out their cash conversion cycle in concrete terms: when money goes out, when it comes in, and what the typical float looks like at any given point in the month. When cash flow gaps arise, financing can provide an important safety net, but only when used strategically.

Strategic Use of Loans and Credit

Access to capital is a double-edged tool. It can fund expansion, modernize operations, or bridge a temporary cash flow shortfall, but borrowing out of panic creates a debt burden that makes an already thin margin unsustainable. The first step is understanding which financing products are available to independent pharmacies. SBA 7(a) and SBA 504 loans are often useful options for owners looking to acquire a business, purchase real estate, or make major capital improvements. For qualified borrowers, these loans can offer competitive terms and repayment structures that better align with business cash flow.

For shorter-term working capital needs, a business line of credit is typically a better fit than a term loan. A revolving line lets an owner draw what's needed, pay it down as reimbursements come in, and avoid paying interest on capital not actively being used. The key is to secure the line before cash becomes tight, because lenders generally prefer to underwrite credit when the business is still financially stable.

Equipment financing is worth considering separately from general working capital. Automated dispensing systems, point-of-sale upgrades, and compounding equipment can be financed through vendor programs or dedicated equipment loans, and the equipment itself often serves as collateral. Because the loan is tied to a specific asset, the terms may be more favorable than those of a general business loan.

Avoid merchant cash advances and revenue-based financing products that market aggressively to small businesses. The effective interest rates on these products can reach triple digits on an annualized basis.

Long-Term Planning For Diversification

The biggest challenge facing community pharmacists is that, unlike other clinical professionals, they are not directly reimbursed for the care they provide. Instead, payment is largely tied to dispensing medications, with PBMs serving as the intermediary. Prescriptions will always be a core service for independent pharmacies. However, long-term financial stability will require pharmacy owners to develop and integrate additional revenue sources that are less dependent on traditional dispensing margins.

Clinical services remain one of the clearest opportunities for independent pharmacies, and many pharmacies have already begun diversifying through enhanced patient services. Survey data conducted by Avalere Health indicate that “the most commonly offered enhanced services” include home delivery (77%); seasonal vaccinations such as influenza and COVID-19 (71%); drug compounding (69%); medication synchronization (67%); and routine immunizations, including Tdap and shingles (65%).⁴ These services not only improve patient access and adherence but can also create revenue streams that are less vulnerable to PBM reimbursement pressures.

Beyond these traditional offerings, pharmacies are increasingly exploring clinical service models that capitalize on pharmacists' expertise. Chronic disease management programs, diabetes education, cardiovascular risk assessments, tobacco cessation services, and weight management programs can strengthen patient relationships while creating new reimbursement opportunities. In states where pharmacists have provider recognition or collaborative practice authority, these services may be billable through medical benefit pathways rather than the pharmacy benefit. According to the National Alliance of State Pharmacy Associations, more than 30 states recognize pharmacists as providers, which lays the groundwork for pharmacists to be reimbursed for providing these clinical services.

Pharmacies are also finding opportunities in specialized service lines. Medication packaging and adherence support for older adults, long-term care-at-home services, pharmacogenomic testing consultations, point-of-care testing, and employer-sponsored wellness programs can generate revenue while addressing unmet community needs. Others have built niche expertise in areas such as hormone replacement therapy, veterinary compounding, fertility medications, or specialty pharmacy services, allowing them to differentiate themselves from larger competitors.^5-8

Technology-enabled services represent another area of growth. Remote patient monitoring, chronic care management support, and telehealth partnerships are emerging opportunities, particularly when pharmacies collaborate with providers and align services with reimbursement and workflow support. Independent pharmacies are often well positioned to participate because of their accessibility, established patient relationships, and frequent touchpoints with patients.^9-11

However, diversification should not be pursued simply because a service is available. What succeeds in one market may fail in another. Before investing in a new service line, owners should carefully evaluate community demand, reimbursement potential, staffing requirements, workflow implications, documentation burden, and expected return on investment. A successful diversification strategy aligns with both the needs of the patient population and the pharmacy’s operational capacity.

The goal is not to replace dispensing revenue but to reduce reliance on any single revenue source. Pharmacies that develop multiple complementary income streams are often better equipped to weather reimbursement cuts, payer disruptions, and other market pressures while continuing to serve their communities.

The financial challenges facing independent pharmacy owners are unlikely to disappear in the near term. Reimbursement pressures, rising costs, and ongoing market consolidation will continue to test the profession’s resilience. However, pharmacies that understand their financial performance, actively manage cash flow, use debt strategically, and diversify revenue streams will be better positioned not only to survive but also to continue to serve patients for years to come.

REFERENCES

1. National Community Pharmacists Association. Report for January 2025 Survey of Independent Pharmacy Owners/Managers: Executive Summary. National Community Pharmacists Association. January 27, 2025. Accessed June 8, 2026. https://ncpa.org/sites/default/files/2025-01/1.27.2025-FinalExecSummary.NCPA_.MemberSurvey.pdf

2. Stovall K, Secrest N, Tompkins M. 7 Steps to Strengthen Your Profitability. Independent Pharmacy Cooperative. July 12, 2023. Accessed June 25, 2026. https://www.ipcrx.com/pharmacy-blog/news/improve-profits-now-independent-pharmacy/

3. Hauser R, Halpern L. NCPA: Independent pharmacies facing cash flow gaps under Medicare Drug Price Negotiation Program. Pharmacy Times. March 12, 2026. Accessed June 22, 2026. https://www.pharmacytimes.com/view/ncpa-independent-pharmacies-facing-cash-flow-gaps-under-medicare-drug-price-negotiation-program

4. Letourneau N, Scott M, Sitkowski A, Frieder M. Independent pharmacy challenges and adaptive strategies. Avalere Health. September 3, 2025. Accessed June 8, 2026. https://advisory.avalerehealth.com/insights/independent-pharmacy-challenges-and-adaptive-strategies

5. Gregory T. Long-term care at home: how your pharmacy can help patients age in place. RedSail Technologies. July 15, 2025. Accessed June 22, 2026. https://www.redsailtechnologies.com/blog/long-term-care-at-home

6. Hayashi M, Hamdy DA, Mahmoud SH. Applications for pharmacogenomics in pharmacy practice: a scoping review. Res Social Adm Pharm. 2022;18(7):3094-3118. doi:10.1016/j.sapharm.2021.08.009

7. Koski RR, Klepser N, Koski M, Klepser M, Klepser D. Community pharmacist-provided test and treat programs for acute infectious conditions. J Am Coll Clin Pharm. 2023;6(9):1030-1040. doi:10.1002/jac5.1793

8. Gatwood J, Hanley R, Moore JS, Hohmeier K. Community pharmacist led, employer-based wellness services: a pilot study. Res Social Adm Pharm. 2019;15(5):615-618. doi:10.1016/j.sapharm.2018.06.008

9. Why pharmacists are essential to remote patient monitoring expansion. ThoroughCare. April 18, 2023. Accessed June 22, 2026. https://www.thoroughcare.net/blog/remote-patient-monitoring-pharmacy

10. Chronic care management offers high reimbursement for low investment. PBA Health. March 17, 2022. Accessed June 22, 2026. https://www.pbahealth.com/elements/chronic-care-management-offers-high-reimbursement-for-low-investment/

11. Remote patient monitoring (RPM). Independent Pharmacy Cooperative. Accessed June 22, 2026. https://www.ipcrx.com/pharmacy-services-and-business-consulting/remote-patient-monitoring/